Other impacts include a 15% reduction in the number of people provided with treatment for drug-resistant TB, a 21% reduction in the number of people given TB preventive treatment and a fall in global spending on TB diagnostic, treatment and prevention services between 2019 and 2020.
The pandemic has refocused attention on how infectious diseases transmit from person to person and has catalysed innovations in sampling and diagnostics. The disruption to TB services during the pandemic has simply highlighted just how important it will be going forward that testing for and treating TB are made simpler and easier to access, as well as, TB prevention does not slip off the radar.
Shobha Shukla - CNS (Citizen News Service)
(Shobha Shukla is the founding Managing Editor of CNS (Citizen News Service) and coordinates Asia Pacific Media Alliance for Health and Development. She is a noted feminist and development justice crusader. Follow her on Twitter @Shobha1Shukla or read www.bit.ly/ShobhaShukla)
- Shared under Creative Commons (CC)
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
